Cargando…

Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) remains a devastating disease. However, variations in tumor biology influence individual patient outcomes greatly. We previously showed a strong association between magnetic resonance imaging-based tumor cell estimates and patient survival. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Jungmann, Friederike, Kaissis, Georgios A., Ziegelmayer, Sebastian, Harder, Felix, Schilling, Clara, Yen, Hsi-Yu, Steiger, Katja, Weichert, Wilko, Schirren, Rebekka, Demir, Ishan Ekin, Friess, Helmut, Makowski, Markus R., Braren, Rickmer F., Lohöfer, Fabian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123300/
https://www.ncbi.nlm.nih.gov/pubmed/33922981
http://dx.doi.org/10.3390/cancers13092069
_version_ 1783692863529287680
author Jungmann, Friederike
Kaissis, Georgios A.
Ziegelmayer, Sebastian
Harder, Felix
Schilling, Clara
Yen, Hsi-Yu
Steiger, Katja
Weichert, Wilko
Schirren, Rebekka
Demir, Ishan Ekin
Friess, Helmut
Makowski, Markus R.
Braren, Rickmer F.
Lohöfer, Fabian K.
author_facet Jungmann, Friederike
Kaissis, Georgios A.
Ziegelmayer, Sebastian
Harder, Felix
Schilling, Clara
Yen, Hsi-Yu
Steiger, Katja
Weichert, Wilko
Schirren, Rebekka
Demir, Ishan Ekin
Friess, Helmut
Makowski, Markus R.
Braren, Rickmer F.
Lohöfer, Fabian K.
author_sort Jungmann, Friederike
collection PubMed
description SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) remains a devastating disease. However, variations in tumor biology influence individual patient outcomes greatly. We previously showed a strong association between magnetic resonance imaging-based tumor cell estimates and patient survival. In this study we aimed to transfer this finding to more broadly applied computed tomography (CT) imaging for non-invasive risk stratification. We correlated in vivo CT imaging with histopathological analyses and could show a strong association between regional Hounsfield Units (HU) and tumor cellularity. In conclusion, our study suggests CT-based tumor cell estimates as a widely applicable way of non-invasive tumor cellularity characterization in PDAC. ABSTRACT: Background: PDAC remains a tumor entity with poor prognosis and a 5-year survival rate below 10%. Recent research has revealed invasive biomarkers, such as distinct molecular subtypes, predictive for therapy response and patient survival. Non-invasive prediction of individual patient outcome however remains an unresolved task. Methods: Discrete cellularity regions of PDAC resection specimen (n = 43) were analyzed by routine histopathological work up. Regional tumor cellularity and CT-derived Hounsfield Units (HU, n = 66) as well as iodine concentrations were regionally matched. One-way ANOVA and pairwise t-tests were performed to assess the relationship between different cellularity level in conventional, virtual monoenergetic 40 keV (monoE 40 keV) and iodine map reconstructions. Results: A statistically significant negative correlation between regional tumor cellularity in histopathology and CT-derived HU from corresponding image regions was identified. Radiological differentiation was best possible in monoE 40 keV CT images. However, HU values differed significantly in conventional reconstructions as well, indicating the possibility of a broad clinical application of this finding. Conclusion: In this study we establish a novel method for CT-based prediction of tumor cellularity for in-vivo tumor characterization in PDAC patients.
format Online
Article
Text
id pubmed-8123300
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81233002021-05-16 Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging Jungmann, Friederike Kaissis, Georgios A. Ziegelmayer, Sebastian Harder, Felix Schilling, Clara Yen, Hsi-Yu Steiger, Katja Weichert, Wilko Schirren, Rebekka Demir, Ishan Ekin Friess, Helmut Makowski, Markus R. Braren, Rickmer F. Lohöfer, Fabian K. Cancers (Basel) Article SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) remains a devastating disease. However, variations in tumor biology influence individual patient outcomes greatly. We previously showed a strong association between magnetic resonance imaging-based tumor cell estimates and patient survival. In this study we aimed to transfer this finding to more broadly applied computed tomography (CT) imaging for non-invasive risk stratification. We correlated in vivo CT imaging with histopathological analyses and could show a strong association between regional Hounsfield Units (HU) and tumor cellularity. In conclusion, our study suggests CT-based tumor cell estimates as a widely applicable way of non-invasive tumor cellularity characterization in PDAC. ABSTRACT: Background: PDAC remains a tumor entity with poor prognosis and a 5-year survival rate below 10%. Recent research has revealed invasive biomarkers, such as distinct molecular subtypes, predictive for therapy response and patient survival. Non-invasive prediction of individual patient outcome however remains an unresolved task. Methods: Discrete cellularity regions of PDAC resection specimen (n = 43) were analyzed by routine histopathological work up. Regional tumor cellularity and CT-derived Hounsfield Units (HU, n = 66) as well as iodine concentrations were regionally matched. One-way ANOVA and pairwise t-tests were performed to assess the relationship between different cellularity level in conventional, virtual monoenergetic 40 keV (monoE 40 keV) and iodine map reconstructions. Results: A statistically significant negative correlation between regional tumor cellularity in histopathology and CT-derived HU from corresponding image regions was identified. Radiological differentiation was best possible in monoE 40 keV CT images. However, HU values differed significantly in conventional reconstructions as well, indicating the possibility of a broad clinical application of this finding. Conclusion: In this study we establish a novel method for CT-based prediction of tumor cellularity for in-vivo tumor characterization in PDAC patients. MDPI 2021-04-25 /pmc/articles/PMC8123300/ /pubmed/33922981 http://dx.doi.org/10.3390/cancers13092069 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jungmann, Friederike
Kaissis, Georgios A.
Ziegelmayer, Sebastian
Harder, Felix
Schilling, Clara
Yen, Hsi-Yu
Steiger, Katja
Weichert, Wilko
Schirren, Rebekka
Demir, Ishan Ekin
Friess, Helmut
Makowski, Markus R.
Braren, Rickmer F.
Lohöfer, Fabian K.
Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
title Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
title_full Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
title_fullStr Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
title_full_unstemmed Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
title_short Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging
title_sort prediction of tumor cellularity in resectable pdac from preoperative computed tomography imaging
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123300/
https://www.ncbi.nlm.nih.gov/pubmed/33922981
http://dx.doi.org/10.3390/cancers13092069
work_keys_str_mv AT jungmannfriederike predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT kaissisgeorgiosa predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT ziegelmayersebastian predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT harderfelix predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT schillingclara predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT yenhsiyu predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT steigerkatja predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT weichertwilko predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT schirrenrebekka predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT demirishanekin predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT friesshelmut predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT makowskimarkusr predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT brarenrickmerf predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging
AT lohoferfabiank predictionoftumorcellularityinresectablepdacfrompreoperativecomputedtomographyimaging